About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zynex, Inc. ("Zynex" or "the Company") (NASDAQ: ZYXI) for violations of §§10 (b) ...
NEW YORK CITY, NY / ACCESS Newswire / March 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI) securities between March ...
Glancy Prongay & Murray LLP ("GPM") announces that it has filed a class action lawsuit in the United States District Court for the District of Colorado, captioned Tuncel v. Zynex, Inc., et al., Case ...
TriCare, the federal health insurer for the military, has temporarily stopped paying the medical claims of pain management ...
Revealing a significant insider sell on March 18, Thomas Sandgaard, President at Zynex ZYXI, as per the latest SEC filing. What Happened: Sandgaard's recent Form 4 filing with the U.S. Securities and ...
NEW YORK CITY, NY / ACCESS Newswire / March 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Royal Bank of Canada cut shares of Zynex (NASDAQ:ZYXI – Free Report) from an outperform rating to a sector perform rating in a research report sent to investors on Wednesday, Marketbeat.com reports.
Zynex (NASDAQ:ZYXI – Get Free Report) had its price objective lowered by equities researchers at HC Wainwright from $17.00 to $15.00 in a research note issued on Wednesday,Benzinga reports. The ...
Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. ("Zynex" or the "Company") investors concerning the Company's possible violations of federal securities laws. IF YOU ...
The Law Offices of Frank R. Cruz announces an investigation of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) on behalf of investors concerning ...